In this free webinar, learn how multi-omics integration enhances disease characterization and supports biomarker discovery and the development of robust, clinically relevant biomarkers. Attendees will gain insight into how genomics can drive and inform proteomics analysis. The featured speaker will share how proteomics can support genomic insights by expanding knowledge into the expressed/functional proteome. Attendees will learn about the value of integrating proteomics and genomics workflows to reveal biology and biomarkers in combination. The speaker will discuss the advantages of using complementary proteomics approaches — Olink and MS technologies — to drive biological understanding.
TORONTO, Sept. 22, 2025 /PRNewswire/ — Recent advances in high-throughput proteomics have greatly enhanced biomarker discovery by improving the ability to identify and characterize biomarkers, creating new opportunities for understanding.
The success of biomarker discovery efforts depends not only on technological capabilities but also on rigorous cohort design, standardized sample handling, high-quality data generation and scalable informatics solutions.
This webinar will present an integrated approach that combines minimally invasive plasma proteomics with tissue-based proteogenomic analysis to explore the molecular foundations of disease. Specifically, the speaker will discuss the profiling of 500 plasma samples using two complementary high-throughput platforms — mass spectrometry and Olink — and the analysis of matched formalin-fixed paraffin-embedded (FFPE) tissue from a subset of participants through integrated proteomic and genomic workflows.
Key discussion points will include how genomics can inform proteomics, how proteomics reveals downstream protein-level effects, the advantages of integrated proteogenomic strategies in uncovering novel biological insights and the value of employing mass spectrometry and Olink proteomic platforms to achieve a more comprehensive biomarker landscape.
Register for this webinar to learn how multi-omics integration enhances disease characterization and supports biomarker discovery and the development of robust, clinically relevant biomarkers.
Join Jessica Moore, PhD, Senior Scientist II Proteomics, Discovery Life Sciences, for the live webinar on Tuesday, October 7, 2025, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Biomarker Discovery: Integrating Proteomics and Genomics for Comprehensive Biological Insights.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarker-discovery-integrating-proteomics-and-genomics-for-comprehensive-biological-insights-upcoming-webinar-hosted-by-xtalks-302562130.html
SOURCE Xtalks
